#acl +All:read Default
#format wiki
#language en

'''Recurring Meeting of Cleveland Clinic Core Team'''

'''Date:''' May 9, 2017

'''Time:''' 2:00 PM EST

'''Means:''' In person meeting

'''Attendees:'''

 1. Ahmet Erdemir 
 1. Tyler Schimmoeller
 1. Rici Morrill
 1. Benjamin Landis
 1. Tara Bonner

'''Agenda:'''

 1. Discuss immediate action items from past meetings.
  .  http://wiki.simtk.org/multis/RecurringMeetings/2017-05-02
 1. In vivo testing progress. 
 1. Readiness for in vitro testing. 
 1. Data analysis update. 
 1. Modeling & simulation specifications. 
 1. Decide immediate action items for next meeting.
 1. Other. 

'''Immediate Action Items:'''

 * Tammy
  * Continue recruiting and testing for in vivo experimentation. 
 * Tyler
  * Begin documentation of instrumented surgical tool specifications.
  * Prepare for first non-mock in vitro experiment this Thursday.
  * Request CT specification during experiment on Thursday.
  * Summarize imaging specifications.
  * Add data transfer to specifications.
  * Document digital video collection.
 * Robb
  * Continue development of data collection software for instrumented surgical tools.
 * Tara
  * Continue development of data collection software for instrumented surgical tools.
 * Rici 
  * Continue in vivo testing data analysis. 
  * Continue populating data management system with in vivo testing data.
 * Ben
  * Continue developing modeling specifications.
 * Ahmet
  * Compile haptics libraries and SofaHAPI.
  * Send summer vacation schedule to team members.

'''Notes:'''

 1. Discuss immediate action items from past meetings.
  * All action items were related to the recurring agenda items; refer to discussions below.
 1. In vivo testing progress. 
  * Experimentation continued as anticipated.
 1. Readiness for in vitro testing. 
  * LINUS was updated to reflect requested changes from the last meeting.
  * Tyler tested updates and is prepared for the first non-mock test this Thursday. 
  * Coordinate systems were finalized for instrumented surgical tools.
  * The group reviewed in vitro specifications in preparation for the first experiment.
 1. Data analysis update. 
  * Rici presented results from spherical registration marker distance calculations. Uncertainties appear to be acceptable given the resolution of Optotrak.
 1. Modeling & simulation specifications. 
  * Ben has been establishing the full modeling work flow from segmentation to model generation and simulations.
 1. Decide immediate action items for next meeting.
  * See Immediate Action Items above.
 1. Other. 
  * Next week, the team will be at the BMES/FDA conference on medical devices.